2 dividend heroes with yields over 5% I’d buy now

These two stocks have high dividend yields and here’s why I think they can maintain them.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

High dividend yields aren’t always a good thing. We all want to chase the highest paying stock, but sometimes that isn’t the best course of action. That’s because struggling companies might boost the yield to attract investors and sometimes the yield is high simply because the share price has fallen due to the company struggling.

So dividend sustainability is key. Can the business afford its dividend or is a cut on the horizon? A company’s recent history will tell you whether the dividend is sustainable and if the stock is worth your money. Here are two I think are worth the price.

Pharmaceutical giant

GlaxoSmithKline (LSE: GSK) is my first pick, with its tempting dividend yield of 5.5%. It is currently priced at around 1,600p with a P/E ratio of around 20, not the best-looking P/E in the world, but I believe that even with its high price it can still reward investors. GlaxoSmithKline has steadily been paying dividend yields of around 5% to 6% for years now, reliably paying around 80p per share year after year. This reassures me that, despite market fluctuations, GSK can still bring in the money.

Such a high dividend could fluctuate, but CFO Iain MacKay has confirmed GSK’s commitment to the yield for this year. And the future? It has many products that are seeing great results with Ellipta respiratory sales climbing 20% and Nucala seeing 40% growth in Q1 this year. The company has three main areas of income that provide a safety net: consumer healthcare, vaccines and pharmaceuticals. Vaccines sales soared in Q1 due to the Shingrix shingles treatment. This vaccine accounted for £365m of sales, up from £110m in Q1 of 2018, which is more than a fifth of all vaccine revenue for the firm. Vaccine sales as a whole were up 23% in Q1. This huge amount of cash flow helps sustain a healthy dividend yield I believe is worth paying a high price for.

Reality show

ITV (LSE: ITV) is my next pick, with its mouthwatering yield of 7.6%. ITV shares are currently priced around 106p with a P/E ratio of 11.9. That ratio is lower than the UK average and the company has reasonable long-term debt levels of £981m with £424m operating cash flow in the last 12 months. This means an operating-cash-to-total-debt ratio of 40%, demonstrating how the debt is significantly covered.

ITV did well in Q1. Despite total national television viewers dropping 3%, its share of these views rose 24%. Registered ITV hub users have also risen by 29% this year, with statistics showing that there’s at least one ITV hub account in every UK household. These figures highlight how the company has an in-depth share of (and insight into) our TV habits. This is important as it plans to launch targeted ads on the hub accounts that should hopefully boost revenue this year, reassuring investors, despite the challenging TV advertising market.

Furthermore, the return of Love Island has also seen a huge boost in viewership, keeping ITV ahead during prime time TV hours. That upcoming launch of ITV hub tailored ads and an admittedly-modest 1% increase in revenues in Q1 shows the company has growth prospects ahead. With ITV stock prices being so low and a healthy dividend, I think that this undervalued investment is far too tempting to ignore. 

fional has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended ITV. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

As the FTSE indexes sink, these unique dividend shares are making investors money

These two dividend shares are in positive territory for the month and outperforming the major FTSE indexes by a significant…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Down 15% in days, are Rolls-Royce shares suddenly a bargain again?

Rolls-Royce shares have been heading south over the past couple of weeks. This writer thinks that makes sense -- but…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

What would a 40-year-old need to put into an empty SIPP to target monthly passive income of £1,000?

From a standing start at 40, how might someone target a four-figure monthly income stream from their SIPP? Christopher Ruane…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

As the ISA deadline approaches, UK investors have the opportunity to buy cheap shares

In recent weeks, equity markets have fallen significantly due to the conflict in the Middle East. As a result, many…

Read more »

Array of piggy banks in saturated colours on high colour contrast background
Investing Articles

£5k left in a Stocks and Shares ISA? 2 top ETFs to consider buying in April

Ben McPoland highlights a pair of very different ETFs that he thinks could help generate long-term wealth inside an ISA…

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

Could a £20,000 ISA end up generating £20,000 of passive income each year?

Could a Stocks and Shares ISA ultimately cover its own cost each year with the passive income it produces? Christopher…

Read more »

A young black man makes the symbol of a peace sign with two fingers
Investing Articles

2 top stocks to consider buying after this week’s FTSE carnage

Investors looking for beaten-up stocks to buy for the long term have a lot of great options after the recent…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

A stock market crash could be a gift for long-term investors

A stock market crash could present some outstanding buying opportunities. But the key to taking advantage is knowing what to…

Read more »